Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Pharmacogenomics and Personalized Medicine is Scopus-indexed (Q4, CiteScore 0.5). It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1875-6913Verify ISSN ↗1875-6921Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 294 / 328 | 10th | Q4 |
| Genetics (clinical) | 93 / 100 | 7th | Q4 |
| Molecular Medicine | 173 / 179 | 3rd | Q4 |
| Genetics | 350 / 357 | 1st | Q4 |
| Molecular Biology | 407 / 414 | 1st | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present (also 2008–2018), best quartile Q4, CiteScore 0.5.
Current Pharmacogenomics and Personalized Medicine is Q4 in Pharmacology (rank 294 of 328), Q4 in Genetics (clinical) (rank 93 of 100) and Q4 in Molecular Medicine (rank 173 of 179), by CiteScore 2025. It is ranked in 5 subject areas in all.
Current Pharmacogenomics and Personalized Medicine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.5, quartile Q4, 10th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.179, quartile Q4, with an H-index of 23.
Current Pharmacogenomics and Personalized Medicine is published by Bentham Science Publishers. Its print ISSN is 1875-6913 and its online ISSN is 1875-6921.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Pharmacogenomics and Personalized Medicine has an h-index of 23 and a 2-year mean of 0.37 citations per paper (OpenAlex). Its Scopus CiteScore is 0.5, quartile Q4. On 2-year citations it ranks #272 of 319 Scopus journals in Pharmacology.
Current Pharmacogenomics and Personalized Medicine published 33 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from India (83.7%), United States (3.5%) and Pakistan (1.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.